0 followers
Rafael Holdings (NYSE: RFL) is focused on the development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies-- Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd.
Tessera Therapeutics
2 followers
Vaxcyte
2 followers
Immunome
2 followers
Apogee Therapeutics
1 follower
Artiva Biotherapeutics
1 follower
Thermo Fisher Scientific
158 followers
Genentech
150 followers
CRISPR Therapeutics
9 followers
Adverum Biotech
8 followers
Legend Biotech
5 followers
Verve Therapeutics
54 followers
Explore companies